A novel tylophorine analog NK-007 ameliorates colitis through inhibition of innate immune response
Authors:
- Yangguang LiYLYangguang Li
- Meng WuMWMeng Wu
- Xi ChenXCXi Chen
- Lin HanLHLin Han
- Xiucong BaoXBXiucong Bao
- Ziwen WangZWZiwen Wang
- Kailiang WangKWKailiang Wang
- Yanna HuYHYanna Hu
- Xinglong ZhouXZXinglong Zhou
- Zhenzhou WuZWZhenzhou Wu
- Puyue WangPWPuyue Wang
- 1 December 2012
- journal article
- Published by Elsevier in International Immunopharmacology
- Vol. 14 (4) , 487-494
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (30890143, 20872072)
- Tianjin Natural Science Foundation (11JCZDJC20500)
This publication has 40 references indexed in Scilit:
- Inflammation switches the differentiation program of Ly6Chi monocytes from antiinflammatory macrophages to inflammatory dendritic cells in the colonJournal of Experimental Medicine, 2012
- Current status of monoclonal antibody therapy for the treatment of inflammatory bowel diseaseExpert Review of Clinical Immunology, 2010
- Ginkgo biloba attenuates mucosal damage in a rat model of ulcerative colitisPharmacological Research, 2006
- Animal models of inflammatory bowel diseaseJournal of Pharmacological and Toxicological Methods, 2004
- IL-10 gene therapy prevents TNBS-induced colitisGene Therapy, 2002
- Development of anti-TNF therapy for rheumatoid arthritisNature Reviews Immunology, 2002
- Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient miceGastroenterology, 1994
- Acetic Acid-Induced Colitis in the Rat: A Reproducible Experimental Model for Acute Ulcerative ColitisEuropean Surgical Research, 1992
- Inflammatory Bowel DiseaseNew England Journal of Medicine, 1991
- A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in miceGastroenterology, 1990